| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/20/2007 | US20070292511 Duloxetine hydrochloride delayed release formulations |
| 12/20/2007 | US20070292510 Enteric coated particles containing an active ingredient |
| 12/20/2007 | US20070292508 Orally disintegrating dosage forms |
| 12/20/2007 | US20070292507 Supportive Treatment of Liver Disease |
| 12/20/2007 | US20070292505 Controlled release alfuzosin hydrochloride formulation |
| 12/20/2007 | US20070292504 Pharmaceutical formulation containing a release rate controlling composition |
| 12/20/2007 | US20070292503 Oral pharmaceutical composition of poorly water-soluble active substance |
| 12/20/2007 | US20070292502 Chitosan-Embedded or Encapsulated Capsule |
| 12/20/2007 | US20070292500 Novel Extended Release Composition of Venlafaxine Hydrochloride Containing Polyvinyl Acetate |
| 12/20/2007 | US20070292499 Processes for the Preparation of Solid Dosage Forms of Amorphous Valganciclovir Hydrochloride |
| 12/20/2007 | US20070292498 Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
| 12/20/2007 | US20070292497 Method for treating micrometastatic tumors |
| 12/20/2007 | US20070292496 Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics |
| 12/20/2007 | US20070292494 Carbohydrate-Derivatized Liposomes for Targeting Cellular Carbohydrate Recognition Domains of Ctl/Ctld Lectins, and Intracellular Delivery of Therapeutically Active Compounds |
| 12/20/2007 | US20070292493 Pharmaceutical composition and method for the transdermal delivery of calcium |
| 12/20/2007 | US20070292492 Treating acne; tetracycline antibiotic at an ionic strength of at least about 0.05M |
| 12/20/2007 | US20070292489 Method for treatment of wound treatment using aganocides |
| 12/20/2007 | US20070292485 Polyol ester compounds |
| 12/20/2007 | US20070292483 Reducing muscle soreness with glucosamine compositions |
| 12/20/2007 | US20070292482 Delivery System |
| 12/20/2007 | US20070292480 Delivery System for Ingestible Components |
| 12/20/2007 | US20070292479 Film-shaped drug forms for use in the oral cavity (wafers) |
| 12/20/2007 | US20070292478 Medical Implant Provided with Inhibitors of Atp Synthesis |
| 12/20/2007 | US20070292477 Association of Antimicrobial Compounds with Surfaces and Polymers |
| 12/20/2007 | US20070292476 Delivery of ophthalmologic agents to the exterior or interior of the eye |
| 12/20/2007 | US20070292471 Nitric Oxide-Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, and Compositions, Medical Devices, and Uses Thereof |
| 12/20/2007 | US20070292469 Antimicrobial composition |
| 12/20/2007 | US20070292468 Coated jewelry articles to reduce skin irritation |
| 12/20/2007 | US20070292462 Surfactant, and an emulsion-type cosmetic composition and a liposome containing said surfactant |
| 12/20/2007 | US20070292456 Formulations Containing an Immune Response Modifier |
| 12/20/2007 | US20070292450 Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide Antigens |
| 12/20/2007 | US20070292433 Compounds and methods for treatment of chemotherapy-induced anemia |
| 12/20/2007 | US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/20/2007 | US20070292425 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof |
| 12/20/2007 | US20070292419 Treatment with anti-erbb2 antibodies |
| 12/20/2007 | US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance |
| 12/20/2007 | US20070292415 Compositions and methods for the therapy and diagnosis of breast cancer |
| 12/20/2007 | US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances |
| 12/20/2007 | US20070292412 Novel genes and markers in type 2 diabetes and obesity |
| 12/20/2007 | US20070292410 Using mutant superoxide dismutase 1 (SOD1) as tool in diagnosis, prevention and treatment of nervous system disorders |
| 12/20/2007 | US20070292409 Identifying modulators of G protein-coupled receptor kinase 2 (GRK2); treatment and prevention of type 2 diabetes mellitus and insulin resistance in humans |
| 12/20/2007 | US20070292407 Methods of treatment for meconium aspiration syndrome |
| 12/20/2007 | US20070292405 Uses of Erss Modulators |
| 12/20/2007 | US20070292403 Methods of treating a neurological disorder with creatine monohydrate |
| 12/20/2007 | US20070292392 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma |
| 12/20/2007 | US20070292390 Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies |
| 12/20/2007 | US20070292387 Transmucosal delivery of pharmaceutical active substances |
| 12/20/2007 | US20070292385 Phospholipase Inhibitors Localized in the Gastrointestinal Lumen |
| 12/20/2007 | US20070292384 Water soluble micelle-forming and biodegradable cyclotriphosphazene-taxol conjugate anticancer agent and preparation method thereof |
| 12/20/2007 | US20070292383 Use of Surfactant Systems for Reducing Skin-Intrinsic Enzyme Damage |
| 12/20/2007 | US20070292374 Personal care products containing high refractive index esters and methods of preparing the same |
| 12/20/2007 | US20070292371 Composition for promoting and maintaining oral health |
| 12/20/2007 | US20070292357 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/20/2007 | US20070292356 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/20/2007 | US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions |
| 12/20/2007 | US20070292352 derivatives of non-steroidal anti-inflammatory drugs that exhibit selective binding to cyclooxygenase-2 (COX-2) and that comprise functional groups allowing them to be used for medical diagnosis and/or as therapeutic agents; tissue-targeted therapy |
| 12/20/2007 | US20070292350 Method For Testing A Compound For A Therapeutic Effect And A Diagnostic Method |
| 12/20/2007 | US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases |
| 12/20/2007 | US20070289889 Biomarkers For The Prediction Of Drug-In Duced Diarrhea |
| 12/20/2007 | DE20321542U1 Reinstes rac-1-{4-[2-Hydroxy-3-(5-quinolyloxy) propyl]-piperazin-1-ylß-2,2-diphenylethan-1-one-fumarat Purest rac-1- {4- [2-hydroxy-3- (5-quinolyloxy) propyl] -piperazine-1-ylß-2,2-diphenylethan-1-one fumarate |
| 12/20/2007 | DE19943708B4 Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New C13-substituted estra-1,3,5 (10) -triene-3-yl-sulfamate, to their preparation and to pharmaceutical compositions containing these compounds, method |
| 12/20/2007 | DE10325813B4 Prophylaxe und/oder Therapie bei der portalen Hypertonie Prophylaxis and / or therapy of portal hypertension in |
| 12/20/2007 | DE102006028371A1 Mittel gegen Malaria For malaria |
| 12/20/2007 | DE102006027796A1 Flat form medicament preparation based on hydrophilic polymer disintegrates quickly in contact with moisture, useful e.g. to release active agent in body opening/body cavity e.g. for contraception, comprises active agent combination |
| 12/20/2007 | DE102006027790A1 Typ-2-Diabetes Kombinations-Wafer Type 2 diabetes combination wafer |
| 12/20/2007 | DE102006027229A1 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxylic acid amides and their use for the preparation of medicaments |
| 12/20/2007 | DE102004018441B4 D-Homo-17-chlor-16(17)en Steroide D-homo-17-chloro-16 (17) en steroids |
| 12/20/2007 | CA2602555A1 Composition and method for reducing inflammation |
| 12/19/2007 | EP1867718A2 Therapeutically useful synthetic oligonucleotides |
| 12/19/2007 | EP1867673A1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same |
| 12/19/2007 | EP1867656A1 Compound having cyclic structure and use thereof |
| 12/19/2007 | EP1867649A1 Piperidyl-2, 6-dione derivatives used to inhibit cells from releasing tumor necrosis factor |
| 12/19/2007 | EP1867648A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them. |
| 12/19/2007 | EP1867647A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them. |
| 12/19/2007 | EP1867646A1 Cytokine inhibitors |
| 12/19/2007 | EP1867645A1 Variolin derivatives and their use as antitumor agents |
| 12/19/2007 | EP1867644A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 12/19/2007 | EP1867642A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia |
| 12/19/2007 | EP1867641A1 Preventive or remedy for depression or anxiety neurosis |
| 12/19/2007 | EP1867640A1 Agent for treatment of solid tumor |
| 12/19/2007 | EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 12/19/2007 | EP1867636A1 Pyridylmethylsulfone derivative |
| 12/19/2007 | EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents |
| 12/19/2007 | EP1867343A2 Novel compounds |
| 12/19/2007 | EP1867342A1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
| 12/19/2007 | EP1867339A1 Anti-viral agent |
| 12/19/2007 | EP1867336A2 Adminstration of an anti-endotoxin drug by intravenous infusion |
| 12/19/2007 | EP1867335A2 Formulations with angiogenesis-dependent tumour action |
| 12/19/2007 | EP1867334A1 Method of relieving or avoiding side effect of steroid compound |
| 12/19/2007 | EP1867333A1 Pharmaceutical composition comprising condensed indole compound |
| 12/19/2007 | EP1867332A1 Pharmaceutical composition and method using antifungal agent in combination |
| 12/19/2007 | EP1867331A1 Triazole derivative and the use thereof |
| 12/19/2007 | EP1867330A1 Method of improving the storage stability of substance |
| 12/19/2007 | EP1867329A2 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds |
| 12/19/2007 | EP1867327A1 Astaxanthin and esters thereof for protecting neurocytes and treating Parkinson's disease |
| 12/19/2007 | EP1867322A1 Topical composition for the treatment of psoriasis |
| 12/19/2007 | EP1867321A2 A pharmaceutical product adapted for oral transmucosal administration comprising a pharmaceutical agent |
| 12/19/2007 | EP1867293A2 Spine distraction implant |
| 12/19/2007 | EP1866412A2 Ghrelin binding nucleic acids |
| 12/19/2007 | EP1866325A2 Novel crystalline pharmaceutical product |